Patent 7244847 was granted and assigned to Ionis Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.
The present invention is directed to novel benzimidazoles according to representative structures I and II, and their derivatives that possess antibacterial activity. This invention is also directed to compositions including the benzimidazole derivatives, and methods for using the same.